Sonoma Pharmaceuticals (SNOA) Return on Invested Capital (2016 - 2025)

Sonoma Pharmaceuticals' Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.01% for Q4 2025.

• In Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital was 0.01% for Q4 2025 at Sonoma Pharmaceuticals, up from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2021 to a low of 0.01% in Q4 2022.
• Historically, Return on Invested Capital has averaged 0.01% across 5 years, with a median of 0.01% in 2022.
• The sharpest annual moves came in 2021 and 2022: Return on Invested Capital changed 0 bps in 2021, then slipped 1 bps in 2022.
• A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2021, then plunged by 93 bps to 0.01% in 2022, then jumped by 36 bps to 0.01% in 2023, then slipped by 24 bps to 0.01% in 2024, then grew by 14 bps to 0.01% in 2025.
• The last three Return on Invested Capital figures came in at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.